Objectives: Neuromyelitis optica (NMO) is an uncommon but life-threatening demyelinating disorder. With the discovery of the NMO antibody in 2004, diagnostic criteria have been revised
Background: Neuromyelitis optica (NMO) is a rare inflammatory disease. Average age at onset is 35 years. Few data exist on patients with pediatric-onset NMO (p-NMO), with disease onset before age 18 years.
BACKGROUND: Neuromyelitis optica (NMO) is a rare inflammatory disease. Average age at onset is 35 years